CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project investigates a novel antibody therapy aimed at improving motor function in patients with spinal cord injuries. It focuses on a double-blind clinical trial to determine the treatment's efficacy and safety across varying injury severities.
Spinal cord injury is a severe and devastating neurological disorder that leaves patients with permanent paralysis of the body.
No treatment is available today to regenerate interrupted nerve fibers and repair the damaged spinal cord.
The incidence of spinal cord injury is about newly injured 10’000 people per year in the EU, and due to an almost normal life expectancy more than 200’000 patients are living with a spinal cord injury in the EU.
The impact on the individual quality of life is high,…
UNIVERSITAT ZURICH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Heidelberg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Badalona
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
